Purdue Pharma, Shire Pharmaceuticals Group plc deal

SHP sold its U.S. OTC product portfolio to Purdue for $72 million. Sales of the portfolio were about $24 million for the first nine months of 2002. SHP gained the OTC products through its 1999 acquisi...